Russian Regulators have issued Saneca Pharma with a cGMP certificate after inspecting its facility in Hlohovec, Slovakia.
The Slovakian Government has granted Saneca Pharma €1.5m ($1.6m) to invest in ‘green’ API manufacturing and anti-abuse technologies for its opiate-based drugs.
Saneca Pharma received the four-year grant in partnership with organic synthesis specialist, TAU-CHEM Ltd. The two companies have now embarked on complementary research projects that will serve to strengthen Slovakia’s pharmaceutical industry.
Saneca Pharma will invest in its manufacturing site in Slovakia to service a five-year agreement supplying the Menarini Group with controlled release pellets.
More than 300 workers are facing job losses at major pharmaceuticals plants in Clare and Tipperary, many of them highly-skilled and long-serving.
Saneca Pharma says the expanded capabilities will feed demand for small-scale API batches to support clients’ R&D projects.
Slovakia-based CDMO Saneca Pharma announced that it is making significant investment in its API capabilities to support client demand for smaller batch sizes and streamlined scale-up. The company is strengthening its infrastructure and expanding its suite of equipment within its five API production units to reinforce its expertise in opiate and synthetic drug development and production.
Eli Lilly & Co will likely step up the pace of making deals with other drugmakers while aggressively developing new drugs on its own, the company's newly appointed chiefexecutive said on Wednesday.